These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 30720268)
1. Novel Deoxyvasicinone-Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer's Disease. Du H; Liu X; Xie J; Ma F ACS Chem Neurosci; 2019 May; 10(5):2397-2407. PubMed ID: 30720268 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors. Gabr MT; Abdel-Raziq MS Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870 [TBL] [Abstract][Full Text] [Related]
3. Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation. Ma F; Du H Eur J Med Chem; 2017 Nov; 140():118-127. PubMed ID: 28923380 [TBL] [Abstract][Full Text] [Related]
4. Novel deoxyvasicinone and tetrahydro-beta-carboline hybrids as inhibitors of acetylcholinesterase and amyloid beta aggregation. Du H; Jiang X; Ma M; Xu H; Liu S; Ma F Bioorg Med Chem Lett; 2020 Dec; 30(24):127659. PubMed ID: 33137375 [TBL] [Abstract][Full Text] [Related]
5. Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography. Zha X; Lamba D; Zhang L; Lou Y; Xu C; Kang D; Chen L; Xu Y; Zhang L; De Simone A; Samez S; Pesaresi A; Stojan J; Lopez MG; Egea J; Andrisano V; Bartolini M J Med Chem; 2016 Jan; 59(1):114-31. PubMed ID: 26632651 [TBL] [Abstract][Full Text] [Related]
6. Structure-based design, synthesis, and evaluation of structurally rigid donepezil analogues as dual AChE and BACE-1 inhibitors. Gabr MT; Abdel-Raziq MS Bioorg Med Chem Lett; 2018 Sep; 28(17):2910-2913. PubMed ID: 30017317 [TBL] [Abstract][Full Text] [Related]
7. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties. Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057 [TBL] [Abstract][Full Text] [Related]
8. Dual targeting of acetylcholinesterase and tau aggregation: Design, synthesis and evaluation of multifunctional deoxyvasicinone analogues for Alzheimer's disease. Manzoor S; Gabr MT; Rasool B; Pal K; Hoda N Bioorg Chem; 2021 Nov; 116():105354. PubMed ID: 34562674 [TBL] [Abstract][Full Text] [Related]
9. Discovery of Multitarget-Directed Ligands from Piperidine Alkaloid Piperine as a Cap Group for the Management of Alzheimer's Disease. Bhanukiran K; Singh SK; Singh R; Kumar A; Hemalatha S ACS Chem Neurosci; 2023 Aug; 14(15):2743-2760. PubMed ID: 37433759 [TBL] [Abstract][Full Text] [Related]
10. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids. Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907 [TBL] [Abstract][Full Text] [Related]
11. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease. Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034 [TBL] [Abstract][Full Text] [Related]
12. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties. Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Quinolinone Hybrids as Dual Inhibitors of Acetylcholinesterase and Aβ Aggregation for Alzheimer's Disease Therapy. Manzoor S; Gabr MT; Nafie MS; Raza MK; Khan A; Nayeem SM; Arafa RK; Hoda N ACS Chem Neurosci; 2024 Feb; 15(3):539-559. PubMed ID: 38149821 [TBL] [Abstract][Full Text] [Related]
15. Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease. Wang ZM; Cai P; Liu QH; Xu DQ; Yang XL; Wu JJ; Kong LY; Wang XB Eur J Med Chem; 2016 Nov; 123():282-297. PubMed ID: 27484514 [TBL] [Abstract][Full Text] [Related]
16. Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease. Sharma P; Tripathi A; Tripathi PN; Prajapati SK; Seth A; Tripathi MK; Srivastava P; Tiwari V; Krishnamurthy S; Shrivastava SK Eur J Med Chem; 2019 Apr; 167():510-524. PubMed ID: 30784883 [TBL] [Abstract][Full Text] [Related]
17. Claulansine F-Donepezil Hybrids as Anti-Alzheimer's Disease Agents with Cholinergic, Free-Radical Scavenging, and Neuroprotective Activities. Zang Y; Liu K; Wang W; Li C; Ma J; Yang J; Chen X; Wang X; Zhang D Molecules; 2021 Feb; 26(5):. PubMed ID: 33671020 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of lipoic acid - donepezil hybrids for Alzheimer's disease using a straightforward strategy. Luzet V; Allemand F; Richet C; Dehecq B; Bonet A; Harakat D; Refouvelet B; Martin H; Cardey B; Pudlo M Bioorg Med Chem Lett; 2024 Nov; 112():129938. PubMed ID: 39222891 [TBL] [Abstract][Full Text] [Related]
19. Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets. Sarno TA; Talib LL; Joaquim HP; Bram JM; Gattaz WF; Forlenza OV J Alzheimers Dis; 2017; 55(4):1445-1451. PubMed ID: 27858713 [TBL] [Abstract][Full Text] [Related]
20. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease. Tripathi A; Choubey PK; Sharma P; Seth A; Tripathi PN; Tripathi MK; Prajapati SK; Krishnamurthy S; Shrivastava SK Eur J Med Chem; 2019 Dec; 183():111707. PubMed ID: 31561043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]